| Agency |
Contact |
Role or Activities |
| Office for Treatment Improvement (OTI) |
301/443-5053 | Service demonstration projects
Development of State policy guidelines and treatment
protocols
Technical assistance to States and programs
(Methadone Treatment Improvement Project) |
| National Institute on Drug Abuse (NIDA) |
301/443-6245 |
Development of treatment standards regulations for
dispensing narcotic drugs to treat addiction (with FDA)
Development of performance-based reporting system for
MMT programs (Methadone Treatment Quality Assurance
System)
Methadone clinical research/demonstration grants
Cost-effectiveness studies
Development of new medications for treating addictions
Training courses for treatment center staffs |
| Food and Drug Administration (FDA) |
301/443-4177 |
Inspection and enforcement of methadone programs for
compliance with Federal standards regulations |
| Health Resources and Services Administration (HRSA) |
301/443-2086
301/443-0652 |
Primary care\substance abuse grants (with NIDA)
Ryan White Care Program |
| Centers for Disease Control (CDC) |
404/639-3311 |
Policy and program leadership for HIV/AIDS,
tuberculosis, sexually transmitted diseases, and other
infectious diseases
HIV/AIDS service demonstration projects |
| Indian Health Service (IHS) |
505/766-2115 |
Service provider |
| Drug Enforcement Administration (DEA) |
202/307-7250 |
Registration of practitioners using methadone to treat
narcotic addiction
Regulation of methadone as a controlled substance
(programs and providers)
Approval of waivers of regulatory requirements
Approval of narcotic treatment programs
Approval of any narcotic drug used for treating narcotic
addiction
Approval of changes in laboratories used for urine testing by
methadone treatment programs |
| Department of Veterans Affairs (VA) |
202/535-7316 |
Service providers |
| Office of National Drug Control Policy (ONDCP) |
202/467-9890 |
National policy coordination |